Abstract:Human neural progenitors are increasingly being employed in drug screens and emerging cell therapies targeted towards neurological disorders where neurogenesis is thought to play a key role including developmental disorders, Alzheimer's disease, and depression. Key to the success of these applications is understanding the mechanisms by which neurons arise. Our understanding of development can provide some guidance but since little is known about the specifics of human neural development and the requirement that cultures be expanded in vitro prior to use, it is unclear whether neural progenitors obey the same developmental mechanisms that exist in vivo. In previous studies we have shown that progenitors derived from fetal cortex can be cultured for many weeks in vitro as undifferentiated neurospheres and then induced to undergo neurogenesis by removing mitogens and exposing them to supportive substrates. Here we use live time lapse imaging and immunocytochemical analysis to show that neural progenitors use developmental mechanisms to generate neurons. Cells with morphologies and marker profiles consistent with radial glia and recently described outer radial glia divide asymmetrically and symmetrically to generate multipolar intermediate progenitors, a portion of which express ASCL1. These multipolar intermediate progenitors subsequently divide symmetrically to produce CTIP2(+) neurons. This 3-cell neurogenic scheme echoes observations in rodents in vivo and in human fetal slice cultures in vitro, providing evidence that hNPCs represent a renewable and robust in vitro assay system to explore mechanisms of human neurogenesis without the continual need for fresh primary human fetal tissue. Knowledge provided by this and future explorations of human neural progenitor neurogenesis will help maximize the safety and efficacy of new stem cell therapies by providing an understanding of how to generate physiologically-relevant cell types that maintain their identities when placed in diagnostic or transplantation environments.

Stem-cell derived neurosphere assay highlights the effects of viral infection on human cortical development

Early Developmental Origins of Cortical Disorders Modeled in Human Neural Stem Cells

The Effects of Environmental Adversities on Human Neocortical Neurogenesis Modeled in Brain Organoids

Assembloid CRISPR screens reveal impact of disease genes in human neurodevelopment

Using 2D and 3D pluripotent stem cell models to study neurotropic viruses

Real time imaging of human progenitor neurogenesis

Stem cell-based region-specific brain organoids: Novel models to understand neurodevelopmental defects

Recapitulating Cortical Development with Organoid Culture in Vitro and Modeling Abnormal Spindle-Like (ASPM Related Primary) Microcephaly Disease

iPSC-derived three-dimensional brain organoid models and neurotropic viral infections

Understanding neural development and diseases using CRISPR screens in human pluripotent stem cell-derived cultures

A quantitative framework to evaluate modeling of cortical development by neural stem cells.

Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: from 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.

Sustained synchronized neuronal network activity in a human astrocyte co-culture system

In vivo modeling of human neuron dynamics and Down syndrome

Human brain organoids reveal accelerated development of cortical neuron classes as a shared feature of autism risk genes

Massively parallel disruption of enhancers active during human corticogenesis

3D-cultured neural stem cell microarrays on a micropillar chip for high-throughput developmental neurotoxicology

The power of human stem cell-based systems in the study of neurodevelopmental disorders

Human cortical spheroids with a high diversity of innately developing brain cell types

Development and function of human cerebral cortex neural networks from pluripotent stem cells in vitro

Single-cell analysis of prenatal and postnatal human cortical development